flutiform – Delivers high total lung deposition
Adapted from Van Holsbeke C et al. 20141 Error bars represent standard deviation. Estimated by Functional Respiratory Imaging. Peripheral: Airway diameter <1–2mm (after ~9th generation of bronchioles). 3D airway models of the lungs were created from CT scans in 6 asthma patients treated with an ICS/LABA combination therapy.1
flutiform – Delivers a consistently high fine particle fraction
flutiform has comparable efficacy* with a faster onset of action than Seretide® Evohaler®3,4.
* Based on a 12 -week open-label non-inferiority study in patients of 18 years and over using 50/5μg strengths only; primary endpoint FEV₁, P=0.007 demonstrating non-inferiority, secondary endpoint FEV₁, P=0.001.
flutiform is licensed for asthma maintenance therapy. Not for acute symptom relief.5